The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ambrx Biopharma Inc(NASDAQ:AMAM) 
Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system.
Website: https://ambrx.com/
Founded: 2003
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ambrx Biopharma Number of Twitter Followers
Ambrx Biopharma Days Receivable Outstanding ttm (DSO)
Ambrx Biopharma Op Cashflow Per Share ttm
Ambrx Biopharma Free Cashflow Per Share ttm
Ambrx Biopharma Cash Per Share ttm
Ambrx Biopharma P/S ratio ttm
Ambrx Biopharma (GAAP) P/E ratio ttm
Ambrx Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.